We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ANI Pharmaceuticals Inc | NASDAQ:ANIP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.80 | 1.22% | 66.30 | 66.20 | 66.31 | 66.50 | 64.9201 | 65.48 | 55,055 | 19:50:22 |
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2022 financial results on Wednesday, November 9, 2022, prior to market open.
Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:
Date
Wednesday, November 9, 2022
Time
8:00 a.m. ET
Toll free (U.S.)
800-245-3047
Webcast (live and replay)
www.anipharmaceuticals.com, under the “Investors” section
A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-753-6120 and entering access code 1159760.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005339/en/
Investor Relations: Lisa M. Wilson, In-Site Communications, Inc. 212-452-2793 lwilson@insitecony.com
Media: Faith Pomeroy-Ward, ANI Pharmaceuticals 817-807-8044 Faith.pomeroyward@anipharmaceuticals.com
1 Year ANI Pharmaceuticals Chart |
1 Month ANI Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions